Next Article in Journal
Preferred Lung Cancer Screening Modalities in China: A Discrete Choice Experiment
Next Article in Special Issue
Lateralized and Segmental Overgrowth in Children
Previous Article in Journal
Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect
Previous Article in Special Issue
Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
 
 
Review
Peer-Review Record

Direct Interaction of miRNA and circRNA with the Oncosuppressor p53: An Intriguing Perspective in Cancer Research

Cancers 2021, 13(23), 6108; https://doi.org/10.3390/cancers13236108
by Anna Rita Bizzarri and Salvatore Cannistraro *
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3: Anonymous
Cancers 2021, 13(23), 6108; https://doi.org/10.3390/cancers13236108
Submission received: 7 November 2021 / Revised: 1 December 2021 / Accepted: 2 December 2021 / Published: 3 December 2021
(This article belongs to the Special Issue Feature Paper from Journal Reviewers)

Round 1

Reviewer 1 Report

Bizzarri et al. described experimental evidence of interaction between p53 and miRNAs and/or circRNAs. The review is interesting and clearly described. Few comments to improve this review article.

  • It will be helpful to understand if there is a figure summarizing the interaction of p53 and different miRNAs as well as a figure summarizing the interaction of p53 and different circRNAs.
  • Proofreading is necessary. There are many sentences with big spaces between words.

 

Author Response

circRNAs. The review is interesting and clearly described. Few comments to improve this review article

Thank you for your overall positive  comments.

 

- It will be helpful to understand if there is a figure summarizing the interaction of p53 and different miRNAs as well as a figure summarizing the interaction of p53 and different circRNAs.

A new figure   summarizing the interaction of p53 with both miRNAs and circRNAs, has been   added to the manuscript as new Figure 13.

- Proofreading is necessary. There are many sentences with big spaces between words.

Useless spaces between words have been removed.

Reviewer 2 Report

The authors reviewed the direct interaction of several miRNAs and circRNAs with p53 protein. This review manuscript is well written; however, some revisions are required.

 

  1. Several images (miRNAs, complex between p53 and miRNAs, and circRNAs) were shown in this manuscript and these figures were clear and easy to understand. However, the regulation of p53 by these miRNAs and circRNAs was not clear. I recommend the authors to summarize the regulation (inhibition) of p53 by the miRNAs and circRNAs in a Table.
  2. “RNAse III enzyme”->”RNase III enzyme” (P3L36). “see Fig.7B”->”see Fig.8B?” (P14L2).

Author Response

  1. -Several images (miRNAs, complex between p53 and miRNAs, and circRNAs) were shown in this manuscript and these figures were clear and easy to understand. However, the regulation of p53 by these miRNAs and circRNAs was not clear. I recommend the authors to summarize the regulation (inhibition) of p53 by the miRNAs and circRNAs in a Table.

A Table which summarizes the proposed regulation as induced by the binding of miRNAs  and circRNAs to p53 has been added to the manuscript  (see  new Table 1).

 

  1. “RNAse III enzyme”->”RNase III enzyme” (P3L36). “see Fig.7B”->”see Fig.8B?” (P14L2).

These typos have been corrected.

 

Reviewer 3 Report

The authors summarized the non-coding RNAs (miRNA and circRNA) that involved in the regulation networks of p53, the star molecular in cancer research. The paper is well-organised. However, I want to suggest one minor change about abbreviation.

Abbreviations must be spelled out at first mention in the paper. But the authors did not explain some of them at the first time, such as MDM2 and COP1. Furthermore, the authors did not give the explanation of some abbreviations in the paper, such like TUP and I-TASSER et al. 

Author Response

Abbreviations must be spelled out at first mention in the paper. But the authors did not explain some of them at the first time, such as MDM2 and COP1. Furthermore, the authors did not give the explanation of some abbreviations in the paper, such like TUP and I-TASSER et al

All the abbreviations have been now explained in the text.

Back to TopTop